Barthel Index Score Predicts Mortality in Elderly Heart Failure - A Goal of Comprehensive Cardiac Rehabilitation.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
24 12 2021
Historique:
pubmed: 22 9 2021
medline: 14 4 2022
entrez: 21 9 2021
Statut: ppublish

Résumé

A strategy to predict mortality in elderly heart failure (HF) patients has not been established.Methods and Results:We retrospectively enrolled 413 HF patients aged ≥65 years (mean age 78 years) who had received comprehensive cardiac rehabilitation (CR) during hospitalization. Basic activities of daily life were assessed before discharge using the Barthel index (BI). Of 413 HF patients, 116 (28%) died during a median follow-up period of 1.90 years (interquartile range 1.20-3.23 years). An adjusted dose-dependent association analysis showed that the hazard ratio (HR) of mortality increased in an almost linear manner as the BI score decreased, and that a BI score of 85 corresponded to an HR of 1.0. Kaplan-Meier survival curves showed that the survival rate was lower for patients with a low BI (<85) than for those with a high BI (≥85; 65% vs. 74%, respectively; P=0.007). In multivariate Cox regression analyses, low BI was independently associated with higher mortality after adjusting for predictors, including B-type natriuretic peptide. Inclusion of the BI into the adjusted model improved the accuracy of the prediction of mortality. A BI score <85 at the time of discharge is associated with increased mortality independent of known prognostic markers, and achieving functional status with a BI score ≥85 by comprehensive CR during hospitalization may contribute to favorable outcomes in elderly HF patients.

Sections du résumé

BACKGROUND
A strategy to predict mortality in elderly heart failure (HF) patients has not been established.Methods and Results:We retrospectively enrolled 413 HF patients aged ≥65 years (mean age 78 years) who had received comprehensive cardiac rehabilitation (CR) during hospitalization. Basic activities of daily life were assessed before discharge using the Barthel index (BI). Of 413 HF patients, 116 (28%) died during a median follow-up period of 1.90 years (interquartile range 1.20-3.23 years). An adjusted dose-dependent association analysis showed that the hazard ratio (HR) of mortality increased in an almost linear manner as the BI score decreased, and that a BI score of 85 corresponded to an HR of 1.0. Kaplan-Meier survival curves showed that the survival rate was lower for patients with a low BI (<85) than for those with a high BI (≥85; 65% vs. 74%, respectively; P=0.007). In multivariate Cox regression analyses, low BI was independently associated with higher mortality after adjusting for predictors, including B-type natriuretic peptide. Inclusion of the BI into the adjusted model improved the accuracy of the prediction of mortality.
CONCLUSIONS
A BI score <85 at the time of discharge is associated with increased mortality independent of known prognostic markers, and achieving functional status with a BI score ≥85 by comprehensive CR during hospitalization may contribute to favorable outcomes in elderly HF patients.

Identifiants

pubmed: 34544962
doi: 10.1253/circj.CJ-21-0584
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-78

Auteurs

Satoshi Katano (S)

Division of Rehabilitation, Sapporo Medical University Hospital.

Toshiyuki Yano (T)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Katsuhiko Ohori (K)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Department of Cardiology, Hokkaido Cardiovascular Hospital.

Hidemichi Kouzu (H)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Ryohei Nagaoka (R)

Division of Rehabilitation, Sapporo Medical University Hospital.

Suguru Honma (S)

Department of Rehabilitation, Sapporo Cardiovascular Hospital.

Kanako Shimomura (K)

Department of Rehabilitation, Hakodate Goryokaku Hospital.

Takuya Inoue (T)

Division of Rehabilitation, Hokuto Hospital.

Yuhei Takamura (Y)

Department of Rehabilitation, Hokkaido Ohno Memorial Hospital.

Tomoyuki Ishigo (T)

Division of Hospital Pharmacy, Sapporo Medical University Hospital.

Ayako Watanabe (A)

Division of Nursing, Sapporo Medical University Hospital.

Masayuki Koyama (M)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Department of Public Health, Sapporo Medical University School of Medicine.

Nobutaka Nagano (N)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Takefumi Fujito (T)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Ryo Nishikawa (R)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Wataru Ohwada (W)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.

Akiyoshi Hashimoto (A)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Division of Health Care Administration and Management, Sapporo Medical University School of Medicine.

Masaki Katayose (M)

Second Division of Physical Therapy, Sapporo Medical University School of Health Sciences.

Sumio Ishiai (S)

Department of Rehabilitation, Sapporo Medical University School of Medicine.

Tetsuji Miura (T)

Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Hokkaido University of Science.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH